# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-031719
Filing Date
2025-10-24
Accepted
2025-10-24 16:02:41
Documents
19
Period of Report
2025-12-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | aytu20250915_def14a.htm iXBRL | DEF 14A | 725880
6 |  | card01.jpg | GRAPHIC | 241124
7 |  | card02.jpg | GRAPHIC | 183542
8 |  | netloss.jpg | GRAPHIC | 76273
9 |  | tsr2026.jpg | GRAPHIC | 75003
| Complete submission text file | 0001437749-25-031719.txt |  | 2692835

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | aytu-20250630.xsd | EX-101.SCH | 4557
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | aytu-20250630_def.xml | EX-101.DEF | 1750
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | aytu-20250630_lab.xml | EX-101.LAB | 1775
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | aytu-20250630_pre.xml | EX-101.PRE | 714
21 | EXTRACTED XBRL INSTANCE DOCUMENT | aytu20250915_def14a_htm.xml | XML | 118513

Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 251416150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)